Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI)

MBL Life Sciences

Catalog No.: MBL-TS-TCR02-1

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: PE
• Immunogen: HLA-A*24:02 PBF145-153-AYRPVSRNI
• Class: others
• Formulation: 0.5 mM EDTA, 0.2% BSA, 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 0.09% NaN3.